Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 648-652

  Nepom, Gerald T ^a   Domeier, Mary Ellen ^a   Ou, Dawei ^b   Kovats, Susan ^a   Mitchell, Leslie Ann ^b   Tingle, Aubrey J ^b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

class II histocompatibilily molecules; HLA genes; peptide vaccines

Indexed keywords

EPITOPE; HLA DR ANTIGEN; RUBELLA VACCINE; VIRUS ENVELOPE PROTEIN;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RUBELLA VIRUS; VIRUS ENVELOPE;

ALLELES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDES; RUBELLA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0030989601     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00194-6     Document Type: Article

References (36)

1. Marshall, K.W., Liu, A.F., Canales, J. et al. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol. 1994, 152, 4946-4957
2. Hammer, J., Belunis, C., Bolin, D. et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. natl Acad. Sci. USA 1994, 91, 4456-4460
3. Cotner, T. Factors governing the binding and recognition of foreign and self-peptides by MHC class II. Autoimmunity 1993, 16, 57-67
4. Falk, K., Rötzschke, O., Stevanovic, S. et al. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 1994, 39, 230-242
5. O'Sullivan, D., Sidney, J., Appella, E. et al. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 1990, 145, 1799-1808
6. Rothbard, J.B. and Gefter, M.L. Interactions between immunogenic peptides and MHC proteins. A. Rev. Immunol. 1991, 9, 527-565
7. Sette, A., Buus, S., Appella, E. et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. natl Acad. Sci. USA 1989, 86, 3296-3300
8. Stern, L.J., Brown, J.H., Jardetzky, T.S. et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368, 215-221
9. Hammer, J., Valsasnini, P., Tolba, K. et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993, 74, 197-203
10. Hill, C.M., Liu, A., Marshall, K.W. et al. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 1994, 152, 2890-2898
11. Krieger, J.I., Karr, R.W., Grey, H.M. et al. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 1991, 146, 2331-2340
12. Sette, A., Sidney, J., Oseroff, C. et al. HLA-DR4Dw4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 1993, 151, 3163-3170
13. Boehncke, W., Takeshita, T., Pendleton, C.D. et al. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 1993, 150, 331-341
14. Crisanti, A., Müller, H., Hilbich, C. et al. Epitopes recognized by human T cells map within the conserved part of the GP190 of P. falciparium. Science 1988, 240, 1324-1326
15. Buus, S., Sette, A., Colon, S.M. et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 1987, 235, 1353-1358
16. Wucherpfennig, K.W., Sette, A., Southwood, S. et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 1994, 179, 279-290
17. Berzofsky, J.A., Cease, K.B., Cornette, J.L. et al. Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol. Rev. 1987, 98, 9-52
18. Kilgus, J., Ramagnoli, P., Guttinger, M. et al. Vaccine T-cell epitope selection by a peptide competition assay. Proc. natl Acad. Sci. USA 1989, 86, 1629-1633
19. O'Sullivan, D., Arrhenius, T., Sidney, J. et al. On the interaction of promiscuous antigenic peptides with different DR alleles: identification of common structural motifs. J. Immunol. 1991, 147, 2663-2669
20. Kovats, S., Drover, S., Marshall, W. et al. Coordinate defects in HLA class II expression and antigen presentation in bare lymphocyte syndrome. J. Exp. Med. 1994, 179, 2017-2022
21. Steimle, V., Durand, B., Barras, E. et al. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995, 9, 1021-1032
22. Kovats, S., Nepom, G.T., Coleman, M. et al. Deficient antigen presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J. Clin. Invest. 1995, 96, 217-223
23. Ou, D., Mitchell, L.A., Ho, M. et al. Analysis of overlapping T and B cell antigenic sites on rubella virus E1 envelope protein: influence of HLA-DR4 polymorphism on T-cell clonal recognition. Human Immunol. 1994, 39, 177-187
24. Sidney, J., Oseroff, C., Southwood, S. et al. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DRβ1 alleles. J. Immunol. 1992, 149, 2634-2640
25. del Guercio, M.R, Sidney, J., Hermanson, G. et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 1995, 154, 685-693
26. + cytotoxic T cells: implications for vaccine design. Proc. natl Acad. Sci. USA 1995, 92, 5845-5849
27. Madden, D.R. The three-dimensional structure of peptide-MHC complexes. A. Rev. Immunol. 1995, 13, 587-622
28. Urban, R.G., Chicz, R.M., Lane, W.S. et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. natl Acad. Sci. USA 1994, 91, 1534-1538
29. Momburg, F., Roelse, J., Hammerling, G.J. et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 1994, 179, 1613-1623
30. Tussey, L.G., Rowland-Jones, S., Zheng, T.S. et al. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 1995, 3, 65-77
31. Chicz, R.M., Urban, R.G., Gorga, J.C. et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993, 178, 27-47
32. Vignali, D.A., Urban, R.G., Chicz, R.M. et al. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 1993, 23, 1602-1607
33. Deng, H., Apple, R., Clare-Salzler, M. et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 1993, 178, 1675-1680
34. Alper, C.A., Kruskall, M.S., Marcus-Bagley, D. et al. Genetic prediction of nonresponse to hepatitis B vaccine. N. Engl. J. Med. 1989, 321, 708-712
35. Nepom, G.T. The effects of variations in human immune-response genes (editorial). N. Engl. J. Med. 1989, 321, 751-752
36. Gammon, G., Sercarz, E.E. and Benichou, G. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol. Today 1991, 12, 193-195